Addition Therapeutics
Caroline Gillis, PhD, is a Scientist II at Addition Therapeutics, with previous experience at Novome Biotechnologies as a Scientist II and at Genentech as a Principal Scientific Researcher. Caroline conducted research on various projects related to infectious diseases, microbiomes, and drug targets, showcasing their expertise in microbiology. Caroline's educational background includes a PhD in Microbiology from UT Southwestern Medical Center and a Bachelor of Science in Public Health and Cell & Molecular Biology from Tulane University.
This person is not in any teams
Addition Therapeutics
Addition is transforming genetic medicine by developing RNA-only therapeutics that PRINT any genetic element at specific safe harbor sites